beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?".
Balligand
Jean-Luc
JL
D058671:Adrenergic beta-1 Receptor Antagonists; D058667:Adrenergic beta-3 Receptor Agonists; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D001578:Benzopyrans / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects; D004983:Ethanolamines / Q000494:pharmacology*; D016027:Heart Transplantation; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D000068577:Nebivolol; D019001:Nitric Oxide Synthase / Q000187:drug effects; D022702:Receptors, Adrenergic, beta-3 / Q000096:biosynthesis / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D058671:Adrenergic beta-1 Receptor Antagonists; D058667:Adrenergic beta-3 Receptor Agonists; D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D022702:Receptors, Adrenergic, beta-3; D014665:Vasodilator Agents; D000068577:Nebivolol; D019001:Nitric Oxide Synthase